866-997-4948(US-Canada Toll Free)

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Morocco

Published By :

GlobalData

Published Date : Sep 2018

Category :

Pharmaceutical

No. of Pages : 95 Pages

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Morocco

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Morocco". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Morocco. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Morocco. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Morocco, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Sanofi, GlaxoSmithKline, Leo Pharma, Bayer and Sothema) and major player of the medical device market (Roche Diagnostics)
- Porters five forces analysis for pharmaceutical and medical devices market of Morocco
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Moroccan healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Moroccan healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Moroccan healthcare market.
Table of Contents
Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Porters Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix

List of Tables
Table 1: Pharmaceutical Market, Morocco, Pharmaceutical Sales by Therapeutic Area ($m), 2015 19
Table 2: Salaries vs. Compensation Amounts, Morocco, 2018 52
Table 3: Originator-Generic Price Difference, Morocco, 2014 56
Table 4: Patent Fees, Morocco, 2017 61
Table 5: Trademark Fees, Morocco, 2017 63
Table 6: Trade Fairs, Morocco, 2018-2019 80

List of Figures
Figure 1: Pharmaceutical Market, Morocco, Revenue ($bn), 2010-2017 7
Figure 2: Medical Device Market, Morocco, Revenue ($m), 2013-2018 7
Figure 3: Country Profile, Morocco, 2017 11
Figure 4: Pharmaceutical Market, Morocco, Revenue ($bn), 2010-2017 13
Figure 5: Pharmaceutical Market, Morocco, Revenue Forecast ($bn), 2018-2022 13
Figure 6: Pharmaceutical Exports ($bn), Morocco, 2010-2017 14
Figure 7: Top Export Partners, Morocco, 2017 14
Figure 8: Pharmaceutical Imports ($bn), Morocco, 2010-2016 15
Figure 9: Top Import Partners, Morocco, 2016 15
Figure 10: Pharmaceutical Distribution Channels, Morocco, 2017 16
Figure 11: Generics Market, Morocco, Revenue ($m), 2010-2017 18
Figure 12: OTC Market, Morocco, Revenue ($m), 2010-2017 18
Figure 13: Top Therapeutic Areas (Sales $m), Morocco, 2015 19
Figure 14: Pharmaceutical Market, Morocco, Major Players 21
Figure 15: Medical Device Market, Morocco, Revenue ($m), 2013-2018 38
Figure 16: Healthcare System, Morocco, 2018 50
Figure 17: Drug Reimbursement Process, Morocco, 2018 51
Figure 18: Distribution of Population across Health Insurance Schemes, Morocco, 2016 53
Figure 19: RAMED Targeting System, Morocco, 2016 54
Figure 20: Out-of-Pocket Expenditure (% of total expenditure on health), Morocco, 2009-2015 55
Figure 21: Annual Rate of Change (%), Health Price Index, Morocco, 2010-2017 55
Figure 22: Ministry of Health, Organization Chart, 2018 57
Figure 23: New Drug Approval Process, Morocco, 2017 59
Figure 24: Patent Approval Process, Morocco, 2016 62
Figure 25: Trademark Approval Process, Morocco, 2017 63
Figure 26: Clinical Trial Regulation, Morocco, 2016 65
Figure 27: Pharmacy Regulations, Morocco 67
Figure 28: Labeling and Packaging, Morocco 68
Figure 29: Number of Hospitals, Morocco, 2009-2015 71
Figure 30: Diagnostic Equipment (per million population), Morocco, 2010-2013 71
Figure 31: Hospital Beds (per 1,000 population), Morocco, 2009-2015 72
Figure 32: Public hospitals, Morocco, 2009-2015 72
Figure 33: Private hospitals, Morocco, 2009-2015 72
Figure 34: Life Expectancy (in years), Morocco, 2010-2017 73
Figure 35: Immunization Rate (%), Morocco, 2010-2016 73
Figure 36: PM2.5 (g per m3), Morocco, 2010-2017 74
Figure 37: CO2 Emissions (million tons), Morocco, 2010-2017 74
Figure 38: Physicians (per 1,000 population), Morocco, 2010-2017 75
Figure 39: Nurses (per 1,000 population), Morocco, 2010-2017 75
Figure 40: Major Causes of Mortality (Number of Deaths, 000), Morocco, 2015 76
Figure 41: Major Causes of Male Mortality (Number of Deaths, 000), Morocco, 2015 76
Figure 42: Major Causes of Female Mortality (Number of Deaths, 000), Morocco, 2015 76
Figure 43: Disability-Adjusted Life Years by Major Disease (000), Morocco, 2015 76
Figure 44: Healthcare Expenditure as Percentage of GDP (%), Morocco, 2008-2015 77
Figure 45: Public-Private Share (%), Morocco, 2008-2015 77
Figure 46: Major Components of Healthcare Expenditure (%), Morocco, 2015 78

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *